HCV Peptide (35-44)
HCV Peptide (35-44), a HCV core protein at positions 35 to 44, is a HLA-A2-restricted CTL epitope. HCV Peptide (35-44) inhibits NK cell activity via two distinct mechanisms, directly via KIR2DL2/3, and synergistically via the CD94:NKG2A receptor[1].
Product Specifications
CAS Number
160214-01-7
UNSPSC
12352209
Target
HCV
Type
Peptides
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/hcv-peptide-35-44.html
Purity
99.67
Solubility
H2O : 100 mg/mL (ultrasonic)
Smiles
OC(C=C1)=CC=C1C[C@H](N)C(N[C@@H](CC(C)C)C(N[C@@H](CC(C)C)C(N2[C@@H](CCC2)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCCNC(N)=N)C(NCC(N3[C@@H](CCC3)C(N[C@@H](CCCNC(N)=N)C(N[C@H](C(O)=O)CC(C)C)=O)=O)=O)=O)=O)=O)=O)=O)=O
Molecular Formula
C57H97N19O12
Molecular Weight
1240.50
References & Citations
[1]Cheent KS, et, al. P91 Dual mechanism of NK cell inhibition by the HCV core 35–44 peptide. BMJ journals. 60 (Sup 2) .
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture and light, under nitrogen)
Scientific Category
Peptides
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
bsm-43105M-PE-Cy5 100 µL
PCSK9 Monoclonal Antibody, PE-Cy5 Conjugated
Sign In for Pricing
View Details 
MBS1168778 Inquire
Recombinant Saccharomyces cerevisiae Transcription factor TFIIIB component B'(BDP1) , partial
Sign In for Pricing
View Details ARHGAP22-2795H 25 µg
Recombinant Human ARHGAP22 protein, His-tagged
Sign In for Pricing
View Details